This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Bruker Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM
Transcript : Bruker Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 07:30 AM
Bruker Corporation Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics CI
Bruker Corporation Launches Transformative neofleX? MALDI-TOF System for Spatial Biology Mass Spec Imaging Applications CI
Bruker Prices Offering of 6 Million Shares MT
Bruker Shares Fall Following Public Offering of 6 Million Shares MT
Stifel Adjusts Price Target on Bruker to $77 From $81, Maintains Hold Rating MT
Transcript : Bruker Corporation - Special Call
Bruker Keeps Quarterly Dividend at $0.05 Per Share; Payable June 17 to Shareholders of Record on June 3 MT
Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024 CI
Bruker's NanoString Secures Patent Case Win in Germany MT
Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. CI
Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance MT
Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M MT
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q1 EPS $0.53, vs. Street Est of $0.46 MT
Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Bruker Corporation Revises Earnings Guidance for the Year 2024 CI
Bruker Corporation completed the acquisition of ELITech Group SAS from Tecfin S.À R.L. CI
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference CI
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies MT
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million. CI
Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating MT
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies CI
Bruker Corporation Enters into Term Loan Agreement with Bank of America, N.A CI
Chart Bruker Corporation
More charts
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
66.79 USD
Average target price
83.57 USD
Spread / Average Target
+25.12%
Consensus
  1. Stock Market
  2. Equities
  3. BRKR Stock
  4. News Bruker Corporation
  5. Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating